Pharmaceutical giant AstraZeneca announced its fourth quarter ... Total revenue for Q4 2024 was $14.9bn (€14.4bn), which was a surge of 24%. Core earnings per share (EPS) came up to $2.09 ...

Discover how Cellectis SA (CLLS) is advancing its CAR T therapies and securing financial stability through strategic ...

AstraZeneca has come up short in another phase ... Truqap was off to a decent start, reaching $430 million in 2024 sales in its first full year on the market. However, its $132 million haul ...

In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ ... as a surprise was the UK economy going up by 0.1% in Q4 2024, a welcome reprieve from the sodden economic outlook ...

It is one of the best UK stocks to buy. Overall, 55 hedge funds were bullish on AstraZeneca PLC (NASDAQ:AZN) in Q4 2024, and it was part of 14 billionaire portfolios that had combined stakes worth ...